Surfactant for Neonate With Acute Respiratory Distress Syndrome (ARDS)
Status:
Recruiting
Trial end date:
2022-07-30
Target enrollment:
Participant gender:
Summary
Acute respiratory distress syndrome (ARDS) in neonates has been defined, the role of
surfactant is not clear. This study aimed to determine whether ARDS neonate would benefit
from surfactant when oxygenation deteriorated on mechanical ventilation and to identify any
potential risk factors related to mortality.
Phase:
N/A
Details
Lead Sponsor:
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University